ASCO 2022 Conference Coverage


 

Lecture Summary - ASCO 2022 on the Phase 2 KEYNOTE-C11 Study: Sequential Pembro & Chemo in Newly Diagnosed, Early Unfavorable, or Advanced cHL

42 views
June 24, 2022
Comments 0
Login to view comments. Click here to Login